机译:Nrf2 / ARE途径作为神经退行性疾病的潜在治疗靶点
Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, Wisconsin.;
Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, Wisconsin.|Division of Pharmaceutical Sciences, University of Wisconsin, Madison, Wisconsin.;
Molecular and Cellular Pharmacology, University of Wisconsin, Madison, Wisconsin.;
Division of Pharmaceutical Sciences, University of Wisconsin, Madison, Wisconsin.;
Division of Pharmaceutical Sciences, University of Wisconsin, Madison, Wisconsin.;
Division of Pharmaceutical Sciences, University of Wisconsin, Madison, Wisconsin.;
Division of Pharmaceutical Sciences, University of Wisconsin, Madison, Wisconsin.;
Division of Pharmaceutical Sciences, University of Wisconsin, Madison, Wisconsin.;
Division of Pharmaceutical Sciences, University of Wisconsin, Madison, Wisconsin.;
Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, Wisconsin.|Division of Pharmaceutical Sciences, University of Wisconsin, Madison, Wisconsin.|Molecular and Cellular Pharmacology, University of Wisconsin, Madison, Wisconsin.|Neuroscience Training Program, University of Wisconsin, Madison, Wisconsin.;
机译:Nrf2 / ARE途径作为神经退行性疾病的潜在治疗靶标
机译:Nrf2途径作为亨廷顿病的潜在治疗靶标关于“三萜类CDDO-乙基酰胺和CDDO-三氟乙基酰胺改善亨廷顿病转基因小鼠模型的行为表型和脑病理学的评论”。
机译:NRF2作为神经变性疾病的治疗靶标
机译:星形胶质细胞的体内光学激活作为神经退行性疾病的潜在治疗策略
机译:免疫抑制性缺氧A2腺苷能途径的调节:细菌性败血症的潜在治疗靶标。
机译:Nrf2 / ARE途径作为神经退行性疾病的潜在治疗靶点
机译:Nrf2 / ARE途径作为神经退行性疾病的潜在治疗靶点